The repressed KLF17 promotes the motility and proliferation of human thyroid cancer TPC1 cells by altering the expression of zona occludens-1 (ZO-1) and Snai1, and activating the Akt pathway by upregulating inhibitor of DNA binding 1 (ID1) [21]. Here, TJP1 is linked to thyroid cancer.